Oryzon Gets Spanish Approval for Iadademstat VIVALDI Study in High-Risk AML
Oryzon said it received approval in Spain for the VIVALDI study of iadademstat in high-risk AML.
Oryzon said it received approval in Spain for the VIVALDI study of iadademstat in high-risk AML.